Literature DB >> 15242417

Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996.

Graziella Bogliun1, Ettore Beghi.   

Abstract

OBJECTIVE: To assess the annual incidence of typical Guillain-Barré syndrome (GBS) and its main variants (atypical GBS) in a well-defined population from a large area.
MATERIAL AND METHODS: A population-based prospective survey of GBS was undertaken during the calendar year 1996 in Lombardy, Italy (population 8,891,652). Typical and atypical GBS was diagnosed using the National Institutes of Neurological and Communicative Disorders and Stroke (NINCDS) and Ropper criteria. Eligible cases were hospital inpatients traced through a regional registry, the hospital discharge diagnoses, and an ongoing case-control study. Diagnostic and demographic findings were collected for each case. Complete clinical and laboratory features were available for 80% of cases.
RESULTS: A total of 138 patients (males 74; females 64) aged 2-91 years fulfilled the diagnostic criteria for typical GBS (128) or atypical GBS (10). GBS variants included Miller-Fisher syndrome (four cases), cranial polyneuritis (three cases), pure motor GBS (two cases), and sensory loss with areflexia (one case). The crude annual incidence of GBS was 1.55 per 100,000 (typical GBS 1.43; atypical GBS 0.11; male 1.67; female 1.43; age <35 years, 0.79; 35-54 years, 1.33; 55-74 years, 3.22; 75+ years, 4.67). The overall rate was 1.58 when age- and sex-adjusted to the 1996 Italian population. Previous infections were reported for 37% of patients. The electrophysiological findings indicated demyelination in 51%, primary axonopathy in 14%, and mixed myelin and axon involvement in 27%.
CONCLUSIONS: The incidence of typical GBS is comparable with that in other reports using the NINCDS diagnostic criteria. Atypical GBS accounts for a limited number of cases.

Entities:  

Mesh:

Year:  2004        PMID: 15242417     DOI: 10.1111/j.1600-0404.2004.00272.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  14 in total

Review 1.  Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis.

Authors:  James J Sejvar; Andrew L Baughman; Matthew Wise; Oliver W Morgan
Journal:  Neuroepidemiology       Date:  2011-03-21       Impact factor: 3.282

Review 2.  Immunotherapy of Guillain-Barré syndrome.

Authors:  Shuang Liu; Chaoling Dong; Eroboghene Ekamereno Ubogu
Journal:  Hum Vaccin Immunother       Date:  2018-07-12       Impact factor: 3.452

Review 3.  The Importance of Rare Subtypes in Diagnosis and Treatment of Peripheral Neuropathy: A Review.

Authors:  Brian C Callaghan; Raymond S Price; Kevin S Chen; Eva L Feldman
Journal:  JAMA Neurol       Date:  2015-12       Impact factor: 18.302

4.  Acute bilateral vision deficit as the initial symptom in Guillain-Barre syndrome: A case report.

Authors:  Hui-Jun Wen
Journal:  Exp Ther Med       Date:  2018-07-18       Impact factor: 2.447

5.  Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database.

Authors:  Clarence C Tam; Sarah J O'Brien; Irene Petersen; Amir Islam; Andrew Hayward; Laura C Rodrigues
Journal:  PLoS One       Date:  2007-04-04       Impact factor: 3.240

6.  Bickerstaff's brainstem encephalitis associated with anti-GM1 and anti-GD1a antibodies.

Authors:  Jonathan Cleaver; Richard James; Gurjit Chohan; Paul Lyons
Journal:  BMJ Case Rep       Date:  2020-09-18

7.  Case of Bickerstaff encephalitis with positive glutamic acid decarboxylase antibodies.

Authors:  Hussnain Javaid; Urwa Ejaz; Zbigniew Slowinski
Journal:  BMJ Case Rep       Date:  2020-06-29

8.  Guillain-Barré syndrome: clinical profile and management.

Authors:  Sreenivasa Rao Sudulagunta; Mahesh Babu Sodalagunta; Mona Sepehrar; Hadi Khorram; Shiva Kumar Bangalore Raja; Shyamala Kothandapani; Zahra Noroozpour; Mohammed Aheta Sham; Nagendra Prasad; Sony Parethu Sunny; Munawar Dhanish Mohammed; Rekha Gangadharappa; Ranjitha Nidsale Sudarshan
Journal:  Ger Med Sci       Date:  2015-09-21

9.  Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from Qatar.

Authors:  Almurtada Razok; Abdullah Shams; Ahmed Almeer; Muhammad Zahid
Journal:  Ann Med Surg (Lond)       Date:  2021-07-03

10.  Epidemiology of childhood Guillan-Barre syndrome in the north west of Iran.

Authors:  Mohammad Barzegar; Saeed Dastgiri; Mohammad H Karegarmaher; Ali Varshochiani
Journal:  BMC Neurol       Date:  2007-08-05       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.